Eshelman Ventures, LLC
CIK 1706673 · last filed 2022-04-04
Eshelman Ventures, LLC is a corporate insider who has filed 19 SEC Form 4 insider transactions across 3 companies since 2017. The most recent filing shows the insider exercised options covering $909 of ARAV on Apr 4, 2022. Across all open-market trades the lifetime net is −$6.2M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $420.3M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$420.34M
3
19
-$6.22M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Aravive, Inc. (ARAV) Delisted | Director | 9,211,769 | $0.04 | $369.4K | $0 | 6 | 2022-04-04 |
| LQDA | 10%+ Owner | 5,258,232 | $79.94 | $420.34M | -$10.72M | 6 | 2021-01-26 |
| G1 Therapeutics, Inc. (GTHX) Delisted | 10%+ Owner | 3,139,151 | $7.15 | $22.44M | $4.50M | 1 | 2017-05-24 |
Recent Filings
19 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2022-04-04 | Aravive, Inc. (ARAV) Delisted | Exer (M) | +9,090,910 | $909 | EDGAR |
| 2022-01-05 | Aravive, Inc. (ARAV) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-09-13 | Aravive, Inc. (ARAV) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-02-17 | Aravive, Inc. (ARAV) Delisted | Grant (A) | +5,750,000 | $41.92M | EDGAR |
| 2021-01-26 | LQDA | Sell (S) | −2,438,574 | -$7.22M | EDGAR |
| 2021-01-22 | LQDA | Sell (S) | −656,500 | -$1.94M | EDGAR |
| 2021-01-19 | LQDA | Sell (S) | −54,000 | -$162.5K | EDGAR |
| 2021-01-13 | LQDA | Sell (S) | −225,718 | -$691.3K | EDGAR |
| 2020-12-22 | LQDA | Sell (S) | −210,430 | -$659.9K | EDGAR |
| 2020-12-16 | LQDA | Sell (S) | −12,834 | -$40.2K | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.